![Monica Sandberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monica Sandberg
Compliance Officer chez
PLIANT THERAPEUTICS, INC.
Profil
Monica Sandberg is Vice President-Regulatory & Compliance at Pliant Therapeutics, Inc. since 2025.
Dr. Sandberg was Senior Director-Regulatory Affairs at Ultragenyx Pharmaceutical, Inc. in 2019.
Dr. Sandberg completed graduate and doctorate degrees at the University of Southern California and a graduate degree at the University of Kalmar.
Postes actifs de Monica Sandberg
| Sociétés | Poste | Début |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Compliance Officer | 01/12/2025 |
Anciens postes connus de Monica Sandberg
| Sociétés | Poste | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Conseiller Juridique Général | 01/10/2019 |
Formation de Monica Sandberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kalmar
 University of Kalmar Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
